Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Research article

Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer

Authors: Chuan Wang, Lifang Mai, Chuan Yang, Dan Liu, Kan Sun, Weidong Song, Baoming Luo, Yan Li, Mingtong Xu, Shaoling Zhang, Fangping Li, Meng Ren, Li Yan

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Abstract

Background

Diabetic foot ulceration is receiving more attention because of its high amputation and mortality rate. It is essential to establish the frequency of amputations in people with diabetes after any change to the management of diabetic foot care. The present study aim to compare the frequency of lower-extremity amputations in patients with diabetes foot ulcer over a ten-year period.

Methods

Six hundred forty eight patients with diabetes foot ulcer were retrospectively studied from 2004 to 2013. The clinical features, laboratory results and the lower-extremity amputations were recorded. Major amputation was defined as amputations above the ankle while minor amputation was amputations below the ankle in the present study.

Results

Patients with diabetic foot ulcer were old (age 66.96 ± 11.96 years), with a long duration of diabetes (10.30 ± 6.94 years), high HbA1c (9.19 ± 2.62 %), SBP (144.05 ± 24.18 mmHg), DBP (79.53 ± 11.88 mmHg), LDL-C (2.71 ± 0.93 mmol/L) and had great frequency of neuropathy (62.7 %), retinopathy (45.0 %), nephropathy (39.5 %) and PAD (33.2 %). From 2004 to 2013, the frequency of all lower-extremity amputations is 12.0 % (5.2 % major amputation, 6.8 % minor amputation). The frequency of major amputations decreased from 9.5 % in 2004 and 14.5 % in 2005 to less than 5.0 % after 2006. In particular, there was a significant decline in major amputations of diabetic foot patient with Wagner 3 to 4 wounds. The frequency rate of major amputations in diabetic foot patient with Wagner 3 to 4 wounds fell from 35.7 % in 2004 to 4.4 % after 2007. The change in frequency of minor amputations was fluctuation.

Conclusion

This study demonstrates that the introduction of a multidisciplinary team, coordinated by an endocrinologist and a podiatrist, for managing diabetic foot disease is associated with a reduction in the frequency of major amputations in patients with diabetes.
Literature
1.
go back to reference Wang AH, Xu ZR, Ji LN. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. Zhonghua Yi Xue Za Zhi. 2012;92(4):224–7.PubMed Wang AH, Xu ZR, Ji LN. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. Zhonghua Yi Xue Za Zhi. 2012;92(4):224–7.PubMed
2.
go back to reference Sanjeev KG, Panda S, Surya KS. The etiopathogenesis of the diabetic foot: an unrelenting epidemic. Int J Low Extrem Wounds. 2010;9(3):127–31.CrossRef Sanjeev KG, Panda S, Surya KS. The etiopathogenesis of the diabetic foot: an unrelenting epidemic. Int J Low Extrem Wounds. 2010;9(3):127–31.CrossRef
3.
go back to reference Brem H, Sheehan P, Boulton AJ. Protocol for treatment of diabetic foot ulcers. Am J Surg. 2004;187(5A):1S–10S.CrossRefPubMed Brem H, Sheehan P, Boulton AJ. Protocol for treatment of diabetic foot ulcers. Am J Surg. 2004;187(5A):1S–10S.CrossRefPubMed
4.
go back to reference Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 2001;17(4):246–9.CrossRefPubMed Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 2001;17(4):246–9.CrossRefPubMed
5.
go back to reference Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:225–31.CrossRefPubMed Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:225–31.CrossRefPubMed
6.
go back to reference Apelqvist J et al. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2008;24 Suppl 1:S181–7.CrossRefPubMed Apelqvist J et al. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2008;24 Suppl 1:S181–7.CrossRefPubMed
7.
go back to reference Wagner FJ. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122.CrossRefPubMed Wagner FJ. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122.CrossRefPubMed
8.
go back to reference Krishnan S et al. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care. 2008;31(1):99–101.CrossRefPubMed Krishnan S et al. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care. 2008;31(1):99–101.CrossRefPubMed
9.
go back to reference Jorgensen ME, Almdal TP, Faerch K. Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011. Diabet Med. 2014;31(4):443–7.CrossRefPubMed Jorgensen ME, Almdal TP, Faerch K. Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011. Diabet Med. 2014;31(4):443–7.CrossRefPubMed
10.
go back to reference Nather A et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications. 2008;22(2):77–82.CrossRefPubMed Nather A et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications. 2008;22(2):77–82.CrossRefPubMed
11.
go back to reference Hennis AJ et al. Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention. Diabetes Care. 2004;27(11):2636–41.CrossRefPubMed Hennis AJ et al. Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention. Diabetes Care. 2004;27(11):2636–41.CrossRefPubMed
12.
go back to reference Resnick HE et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004;27(8):1885–91.CrossRefPubMed Resnick HE et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004;27(8):1885–91.CrossRefPubMed
13.
go back to reference Li X et al. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93(1):26–30.CrossRefPubMed Li X et al. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93(1):26–30.CrossRefPubMed
14.
go back to reference Yesil S et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens). 2009;8(4):286–95.CrossRef Yesil S et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens). 2009;8(4):286–95.CrossRef
15.
go back to reference Bakker K, Schaper NC. The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:116–8.CrossRefPubMed Bakker K, Schaper NC. The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:116–8.CrossRefPubMed
Metadata
Title
Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer
Authors
Chuan Wang
Lifang Mai
Chuan Yang
Dan Liu
Kan Sun
Weidong Song
Baoming Luo
Yan Li
Mingtong Xu
Shaoling Zhang
Fangping Li
Meng Ren
Li Yan
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0111-0

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.